Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
97.4M
-
Shares change
-
+97.4M
-
Total reported value, excl. options
-
$1.6B
-
Value change
-
+$1.6B
-
Number of buys
-
157
-
Price
-
$16.41
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2018
161 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q2 2018.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 97.4M shares
of 316M outstanding shares and own 30.81% of the company stock.
Largest 10 shareholders include Fosun International Ltd (20.3M shares), WELLINGTON MANAGEMENT GROUP LLP (10.9M shares), VANGUARD GROUP INC (8.74M shares), FMR LLC (7.94M shares), BlackRock Inc. (5.81M shares), TPG Group Holdings (SBS) Advisors, Inc. (4.11M shares), AMERIPRISE FINANCIAL INC (3.05M shares), MAVERICK CAPITAL LTD (2.78M shares), TCW GROUP INC (2.58M shares), and DIMENSIONAL FUND ADVISORS LP (2.32M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.